These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

531 related articles for article (PubMed ID: 35371342)

  • 1. A Novel Necroptosis-Related miRNA Signature for Predicting the Prognosis of Breast Cancer Metastasis.
    Zheng L; Wang J; Jiang H; Dong H
    Dis Markers; 2022; 2022():3391878. PubMed ID: 35371342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a necroptosis-related prognostic model for uterine corpus endometrial carcinoma.
    Zhang Q; Luo Y; Zhang S; Huang Q; Liu G
    Sci Rep; 2024 Feb; 14(1):4257. PubMed ID: 38383747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel necroptosis-associated miRNA signature predicting prognosis of endometrial cancer and correlated with immune infiltration.
    Ye Z; Jiang Y; Wu J
    Taiwan J Obstet Gynecol; 2023 Mar; 62(2):291-298. PubMed ID: 36965898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of Necroptosis-Related Markers in Head and Neck Carcinoma by Bioinformatics.
    Zheng L; Li M; Gu R; Zhang H; Qi X; Dong H
    J Immunol Res; 2022; 2022():1993023. PubMed ID: 35785035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Novel Defined Necroptosis-Related miRNAs Signature for Predicting the Prognosis of Colon Cancer.
    Yang Z; Lu S; Wang Y; Tang H; Wang B; Sun X; Qu J; Rao B
    Int J Gen Med; 2022; 15():555-565. PubMed ID: 35046713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel-Defined Necroptosis-Related miRNA Signature for Forecasting the Prognosis of Low-Grade Glioma.
    Lu Z; Wang C; Qu T; Feng Y
    Biomed Res Int; 2022; 2022():9957604. PubMed ID: 36199758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel prognostic signature for clear cell renal cell carcinoma constructed using necroptosis-related miRNAs.
    Yu Z; Lu C; Lu B; Gao H; Liang R; Xiang W
    BMC Genomics; 2023 Mar; 24(1):162. PubMed ID: 36991314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A microRNA-clinical prognosis model to predict the overall survival for kidney renal clear cell carcinoma.
    Zhan Y; Zhang R; Li C; Xu X; Zhu K; Yang Z; Zheng J; Guo Y
    Cancer Med; 2021 Sep; 10(17):6128-6139. PubMed ID: 34288551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of MicroRNAs as Breast Cancer Prognosis Markers through the Cancer Genome Atlas.
    Chang JT; Wang F; Chapin W; Huang RS
    PLoS One; 2016; 11(12):e0168284. PubMed ID: 27959953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction of a Necroptosis-Related miRNA Signature for Predicting the Prognosis of Patients With Hepatocellular Carcinoma.
    Meng T; Wang Q; Yang Y; Ren Y; Shi Y
    Front Genet; 2022; 13():825261. PubMed ID: 35495130
    [No Abstract]   [Full Text] [Related]  

  • 11. A Panel of MicroRNA Signature as a Tool for Predicting Survival of Patients with Urothelial Carcinoma of the Bladder.
    Inamoto T; Uehara H; Akao Y; Ibuki N; Komura K; Takahara K; Takai T; Uchimoto T; Saito K; Tanda N; Yoshikawa Y; Minami K; Hirano H; Nomi H; Kato R; Hayashi T; Azuma H
    Dis Markers; 2018; 2018():5468672. PubMed ID: 30026881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Five-microRNA Signature as Prognostic Biomarker in Colorectal Cancer by Bioinformatics Analysis.
    Yang G; Zhang Y; Yang J
    Front Oncol; 2019; 9():1207. PubMed ID: 31799184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of differential expression profile of miRNA in peripheral blood of patients with lung cancer.
    He Q; Fang Y; Lu F; Pan J; Wang L; Gong W; Fei F; Cui J; Zhong J; Hu R; Liang M; Fang L; Wang H; Yu M; Zhang ZF
    J Clin Lab Anal; 2019 Nov; 33(9):e23003. PubMed ID: 31541491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ascites-derived hsa-miR-181a-5p serves as a prognostic marker for gastric cancer-associated malignant ascites.
    Yang Y; Zhang J
    BMC Genomics; 2024 Jun; 25(1):628. PubMed ID: 38914980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioinformatic analysis of peripheral blood miRNA of breast cancer patients in relation with anthracycline cardiotoxicity.
    Yadi W; Shurui C; Tong Z; Suxian C; Qing T; Dongning H
    BMC Cardiovasc Disord; 2020 Feb; 20(1):43. PubMed ID: 32013934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of miRNA-Based Signature as a Novel Potential Prognostic Biomarker in Patients with Breast Cancer.
    Tang J; Ma W; Zeng Q; Tan J; Cao K; Luo L
    Dis Markers; 2019; 2019():3815952. PubMed ID: 31976020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of prognostic markers for hepatocellular carcinoma based on miRNA expression profiles.
    Wang X; Gao J; Zhou B; Xie J; Zhou G; Chen Y
    Life Sci; 2019 Sep; 232():116596. PubMed ID: 31233760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis and Validation of the Prognosis ability of the M7GRelated miRNAs in Lung Adenocarcinoma.
    Qiu X; Chen Y; Zhu X; Gong Z; Yu F; Zhang P; Song Y; Li H
    Asian Pac J Cancer Prev; 2023 Apr; 24(4):1275-1287. PubMed ID: 37116150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA profiling reveals dysregulated microRNAs and their target gene regulatory networks in cemento-ossifying fibroma.
    Pereira TDSF; Brito JAR; GuimarĂ£es ALS; Gomes CC; de Lacerda JCT; de Castro WH; Coimbra RS; Diniz MG; Gomez RS
    J Oral Pathol Med; 2018 Jan; 47(1):78-85. PubMed ID: 29032608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA signature for estimating the survival time in patients with bladder urothelial carcinoma.
    Yerukala Sathipati S; Tsai MJ; Shukla SK; Ho SY; Liu Y; Beheshti A
    Sci Rep; 2022 Mar; 12(1):4141. PubMed ID: 35264666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.